Continuous venovenous hemodiafiltration increased survival more than did continuous hemofiltration in acute renal failure

Affiliations

Comment

Scott Klarenbach et al. ACP J Club. 2007 Jan-Feb.

. 2007 Jan-Feb;146(1):14.

No abstract available

Comment on

Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.
Saudan P, Niederberger M, De Seigneux S, Romand J, Pugin J, Perneger T, Martin PY. Saudan P, et al. Kidney Int. 2006 Oct;70(7):1312-7. doi: 10.1038/sj.ki.5001705. Epub 2006 Jul 19. Kidney Int. 2006. PMID: 16850022 Clinical Trial.

Evaluation of MPA and MPAG removal by continuous venovenous hemodiafiltration and continuous venovenous hemofiltration.
Cussonneau X, Bolon-Larger M, Prunet-Spano C, Bastien O, Boulieu R. Cussonneau X, et al. Ther Drug Monit. 2008 Feb;30(1):100-2. doi: 10.1097/FTD.0b013e3181633667. Ther Drug Monit. 2008. PMID: 18223470
Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial.
van der Voort PH, Boerma EC, Koopmans M, Zandberg M, de Ruiter J, Gerritsen RT, Egbers PH, Kingma WP, Kuiper MA. van der Voort PH, et al. Crit Care Med. 2009 Feb;37(2):533-8. doi: 10.1097/CCM.0b013e318195424d. Crit Care Med. 2009. PMID: 19114909 Clinical Trial.
Continuous venovenous hemodiafiltration in the treatment of acute hyperammonemia.
Braun MC, Welch TR. Braun MC, et al. Am J Nephrol. 1998;18(6):531-3. doi: 10.1159/000013400. Am J Nephrol. 1998. PMID: 9845830
Renal replacement therapy in support of combat operations.
Chung KK, Perkins RM, Oliver JD 3rd. Chung KK, et al. Crit Care Med. 2008 Jul;36(7 Suppl):S365-9. doi: 10.1097/CCM.0b013e31817e302a. Crit Care Med. 2008. PMID: 18594264 Review.
Continuous renal replacement therapy in the adult intensive care unit: history and current trends.
Dirkes S, Hodge K. Dirkes S, et al. Crit Care Nurse. 2007 Apr;27(2):61-6, 68-72, 74-80; quiz 81. Crit Care Nurse. 2007. PMID: 17389414 Review. No abstract available.